Stephan M. Hacker

Stephan M. Hacker

Auto-generated profile, based on publicly available information

Stephan M. Hacker

Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, Leiden, Netherlands, 2333 CC

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2017 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
SHStephan M. Hacker
Stephan M. Hacker
KBKeriann M. Backus
Keriann M. Backus
MLMichael R. Lazear
Michael R. Lazear
SFStefano Forli
Stefano Forli
BCBruno E. Correia
Bruno E. Correia
BCBenjamin F. Cravatt
Benjamin F. Cravatt

9 September 2021 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
MAMikail E. Abbasov
Mikail E. Abbasov
MKMadeline E. Kavanagh
Madeline E. Kavanagh
TITaka-Aki Ichu
Taka-Aki Ichu
MLMichael R. Lazear
Michael R. Lazear
YTYongfeng Tao
Yongfeng Tao
BCBenjamin F. Cravatt
Benjamin F. Cravatt

16 December 2019 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
PLPhilipp Le
Philipp Le
EKElena Kunold
Elena Kunold
RMRobert Macsics
Robert Macsics
KRKatharina Rox
Katharina Rox
MJMegan C. Jennings
Megan C. Jennings
SSStephan A. Sieber
Stephan A. Sieber

29 November 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
PZPatrick R. A. Zanon
Patrick R. A. Zanon
LLLisa Lewald
Lisa Lewald
SHStephan M. Hacker
Stephan M. Hacker
Rapid development of bacterial resistance has led to an urgent need to find new druggable targets for antibiotics. In this context, residue‐specific chemoproteomic approaches enable proteome‐wide identification of binding sites for covalent inhibitors. Described here are easily synthesized isotopically labeled desthiobiotin azide (isoDTB) tags that shortened the chemoproteomic workflow and allowed an increased coverage of cysteines in bacterial systems. They were used to quantify 59 % of all cysteines in essential proteins in Staphylococcus aureus and enabled the discovery of 88 cysteines that showed high reactivity, which correlates with functional importance. Furthermore, 268 cysteines that are engaged by covalent ligands were identified. Inhibition of HMG‐CoA synthase was verified and will allow addressing the bacterial mevalonate pathway through a new target. Overall, a broad map of the bacterial cysteinome was obtained, which will facilitate the development of antibiotics with novel modes‐of‐action.

13 April 2020 in ACS Central Science
Verified
Journal Article
Open access
KBKathrin Bach
Kathrin Bach
BBBert L. H. Beerkens
Bert L. H. Beerkens
PZPatrick R. A. Zanon
Patrick R. A. Zanon
SHStephan M. Hacker
Stephan M. Hacker
Covalent inhibitors have recently seen a resurgence of interest in drug development. Nevertheless, compounds, which do not rely on an enzymatic activity, have almost exclusively been developed to target cysteines. Expanding the scope to other amino acids would be largely facilitated by the ability to globally monitor their engagement by covalent inhibitors. Here, we present the use of light-activatable 2,5-disubstituted tetrazoles that allow quantifying 8971 aspartates and glutamates in the bacterial proteome with excellent selectivity. Using these probes, we competitively map the binding sites of two isoxazolium salts and introduce hydrazonyl chlorides as a new class of carboxylic-acid-directed covalent protein ligands. As the probes are unreactive prior to activation, they allow global profiling even in living Gram-positive and Gram-negative bacteria. Taken together, this method to monitor aspartates and glutamates proteome-wide will lay the foundation to efficiently develop covalent inhibitors targeting these amino acids.

30 October 2025 in Nature Chemistry
Verified
Journal Article
Open access
PDF file
PZPatrick R. A. Zanon
Patrick R. A. Zanon
FYFengchao Yu
Fengchao Yu
PMPatricia Z. Musacchio
Patricia Z. Musacchio
LLLisa Lewald
Lisa Lewald
MZMichael Zollo
Michael Zollo
SHStephan M. Hacker
Stephan M. Hacker
Covalent inhibitors that do not rely on hijacking enzymatic activity have mainly been limited to those targeting cysteine residues. The development of such cysteine-directed covalent inhibitors has greatly profited from the use of competitive residue-specific proteomics to determine their proteome-wide selectivity. Several probes have been developed to monitor other amino acids using this technology, and many more electrophiles exist to modify proteins. Nevertheless, there has been a lack of direct, proteome-wide comparisons of the selectivity of diverse electrophiles. Here we developed an unbiased workflow to analyse electrophile selectivity proteome-wide and used it to directly compare 56 alkyne probes containing diverse reactive groups. In this way, we verified and identified probes to monitor a total of nine different amino acids, as well as the protein amino terminus, across the proteome.